A new study co-authored by a University of Rochester Medical Center researcher has found that the survival rates of extremely pre-term babies has increased significantly in the past decade.
New Company Committed to Developing Life-Changing Medicines for Extremely Preterm Infants and Patients Suffering from Rare Autoimmune Diseases Pipeline Includes Two Programs with Phase 2 Proof-of-Concept